Craniopharyngioma

What changed: Craniopharyngioma

Cancer page →

Every dated change on the records linked to Craniopharyngioma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Guideline2Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-10This recordCraniopharyngioma
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 2

2016 · 1

2016MilestoneCraniopharyngioma
Hypothalamus-sparing surgery recommended
KRANIOPHARYNGEOM 2007 shows radical resection with hypothalamic injury worsens quality of life without improving control.

2015 · 1

2015MilestoneDabrafenib + trametinib
First dramatic response to BRAF/MEK inhibition in papillary craniopharyngioma
Case report (JNCI) leads to the Alliance A071601 trial.

2014 · 1

2014MilestoneBRAF
BRAF V600E found in papillary craniopharyngioma
Brastianos and colleagues (Nature Genetics) show near-universal BRAF V600E in PCP and CTNNB1 in ACP.

2007 · 1

2007GuidelineCraniopharyngioma
Guideline KRANIOPHARYNGEOM 2007; NCI PDQ: Hypothalamic involvement
Hypothalamus-sparing subtotal resection or cyst drainage followed by conformal or proton radiotherapy; intracystic therapy for predominantly cystic tumours.

2005 · 1

2005MilestoneCraniopharyngioma
Nuclear beta-catenin and CTNNB1 mutations define adamantinomatous tumours
A milestone in how this cancer is treated.

1932 · 1

1932MilestoneCraniopharyngioma
Cushing names craniopharyngioma
A milestone in how this cancer is treated.